FDA Import Refusal 799-0866434-5/21/1 — Novartis Pharmaceuticals
The FDA refused shipment 799-0866434-5/21/1 from Novartis Pharmaceuticals (Australia) on Oct 17, 2022. The refused product falls under Drugs and Biologics — CARBAMAZEPINE (ANALGESIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Oct 17, 2022
- Country
- Australia
- Product Category
- Drugs and Biologics
- Product Code
- 60LDY14 CARBAMAZEPINE (ANALGESIC)
- Charges
- 75